Skip to main content
. 2024 Jul 6;14:15564. doi: 10.1038/s41598-024-66482-3

Figure 6.

Figure 6

Impact of JAK/STAT signaling pathway on PDGF-BB-induced HASMC function. (A) The CCK-8 assay was used to investigate the effect of the JAK2/STAT3 signaling pathway inhibitor AG490 on PDGF-BB-induced HASMC viability. (B) The impact of on migration was assessed using the wound healing assay. (C–D) Flow cytometry was employed to evaluate apoptosis and cell cycle distribution after AG490 treatment. The data are expressed as mean ± standard deviation (SD) of three biological replicates. Unpaired Student's t test: **P < 0.01 versus Control group; ##P < 0.01 versus PDGF-BB group.